Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Larimar Therapeutics Inc’s stock clocked out at $4.36, down -4.18% from its previous closing price of $4.55. In other words, the price has decreased by -$4.18 from its previous closing price. On the day, 2.64 million shares were traded. LRMR stock price reached its highest trading level at $4.54 during the session, while it also had its lowest trading level at $4.18.
Ratios:
To gain a deeper understanding of LRMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.46 and its Current Ratio is at 5.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 31 ’25 when Flynn James E bought 9,375,000 shares for $3.20 per share. The transaction valued at 30,000,000 led to the insider holds 9,538,945 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 373174112 and an Enterprise Value of 239264112.
Stock Price History:
The Beta on a monthly basis for LRMR is 1.07, which has changed by -0.39862067 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $9.50, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 7.96%, while the 200-Day Moving Average is calculated to be 37.72%.
Shares Statistics:
It appears that LRMR traded 2.48M shares on average per day over the past three months and 7157690 shares per day over the past ten days. A total of 64.03M shares are outstanding, with a floating share count of 48.59M. Insiders hold about 43.23% of the company’s shares, while institutions hold 41.97% stake in the company. Shares short for LRMR as of 1759190400 were 8944347 with a Short Ratio of 3.60, compared to 1756425600 on 6402490. Therefore, it implies a Short% of Shares Outstanding of 8944347 and a Short% of Float of 15.709999999999999.
Earnings Estimates
The stock of Larimar Therapeutics Inc (LRMR) is currently being evaluated by 8.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.36 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.57 and -$1.76 for the fiscal current year, implying an average EPS of -$1.68. EPS for the following year is -$1.67, with 7.0 analysts recommending between -$1.18 and -$2.22.
